Reprogramming Cell-Surface Protein Turnover for Autoimmune Disease
- Harnessing cell-surface E3 ligases to degrade pathogenic immune receptors
- Achieving potent, cell-selective target removal beyond conventional antibody blockade
- Sharing early mechanistic insights and considerations for degrader optimisation